Cargando…
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer
BACKGROUND: Ovarian cancer (OC) is characterized by a low response rate and high frequency of resistance development to currently available treatments. The therapeutic potential of histone methyltransferase DOT1L inhibitor in OC cells has been demonstrated, but optimal efficacy and safety of this ta...
Autores principales: | Alexandrova, Elena, Lamberti, Jessica, Memoli, Domenico, Quercia, Claudia, Melone, Viola, Rizzo, Francesca, Tarallo, Roberta, Giurato, Giorgio, Nassa, Giovanni, Weisz, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636786/ https://www.ncbi.nlm.nih.gov/pubmed/36333801 http://dx.doi.org/10.1186/s12935-022-02740-6 |
Ejemplares similares
-
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors
por: Alexandrova, Elena, et al.
Publicado: (2022) -
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer
por: Salvati, Annamaria, et al.
Publicado: (2022) -
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells
por: Salvati, Annamaria, et al.
Publicado: (2019) -
Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells
por: Nassa, Giovanni, et al.
Publicado: (2019) -
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)